数据链接：
官方服务：
资源简介：
Predicting factor of RA failure treatment.
应用场景：
创建时间：
2023-02-02
相关数据集
Association between analysed polymorphisms and response to Adalimumab treatment in RA patients.
Association between analysed polymorphisms and response to Adalimumab treatment in RA patients.
NIAID Data Ecosystem60
Summary of details from MTX users for RA who exhibited ALT/AST levels > 3 times the ULN during a 1-year follow-up period.
Summary of details from MTX users for RA who exhibited ALT/AST levels > 3 times the ULN during a 1-year follow-up period.
Figshare2018-08-24 更新20
Phase 2 Study Of The Effects Of Open-Label CP-690,550 And Double-Blind Atorvastatin On Lipids In Patients With Active Rheumatoid Arthritis
All patients will be in instructed to eat a therapeutic lifestyle diet and will receive CP-690,550 throughout the 12 weeks of this study. After 6 weeks, half will receive the cholesterol lowering ag
DataCite Commons2025-02-10 更新10
Dataset from A Phase IIIb Open-label run-in Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety/Efficacy of Certolizumab Pegol Administered Concomitantly With Stable-dose Methotrexate in Patients With Active Rheumatoid Arthritis.
During the run-in period, CZP will be administered at 400 mg (2 injections) at Wks 0, 2, and 4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and 16. At Wk 18 p
NIAID Data Ecosystem20
Demographic data of RA patients receiving bDMARDs and tsDMARDs.
Demographic data of RA patients receiving bDMARDs and tsDMARDs.
NIAID Data Ecosystem20
